Trends in Retinopathy of Prematurity Care in the United States 2009-2018: A Nationwide Analysis Using National Inpatient Sample
- PMID: 36280204
- DOI: 10.1016/j.oret.2022.10.010
Trends in Retinopathy of Prematurity Care in the United States 2009-2018: A Nationwide Analysis Using National Inpatient Sample
Abstract
Purpose: Retinopathy of prematurity (ROP) represents a leading cause of childhood blindness. The purpose of our study was to evaluate incidence, trends in cost and length of hospital stay, and risk factors for ROP using a publicly available population-based dataset, the National Inpatient Sample.
Design: This cross-sectional study analyzed data from 2009 to 2018 using the National Inpatient Sample.
Participants: Premature neonates (n = 717 277) who met the screening criteria for ROP with gestational age of ≤ 30 weeks or birthweight (BW) of ≤ 1500 g were identified.
Methods: Database analysis.
Main outcome measures: Incidence, demographics, risk factors for ROP development, trends in cost, and length of stay were evaluated.
Results: In total, incidence of ROP increased from 11% in 2009 to 15% in 2018 (P < 0.001). Multivariate logistic regression model of ROP development showed its associations with female sex (odds ratio [OR], 1.13; 95% confidence interval [CI], 1.10-1.17), Hispanic (OR, 1.10; 95% CI, 1.03-1.18), and Black (OR, 0.91; 95% CI 0.86-0.96) ethnicity. Neonates with lower BWs, particularly those in the 500- to 999-g subgroup (OR, 2.64; 95% CI, 2.44-2.85) and younger gestational ages, particularly those born between 25 and 28 weeks gestational age (OR, 2.41; 95% CI, 2.25-2.58), had increased risk of developing ROP. Comorbidities associated with the development of ROP were perinatal jaundice (OR, 1.84; 95% CI, 1.74-1.94), patent ducts arteriosus (OR, 1.67; 95% CI, 1.60-1.75), intraventricular hemorrhage (OR, 1.41; 95% CI, 1.35-1.48), perinatal infection (OR, 1.84; 95% CI, 1.74-1.94), and respiratory distress syndrome (OR, 1.05; 95% CI, 1.01-1.10).
Conclusions: Retinopathy of prematurity develops in about 1 of 10 premature infants and incidence has been shown to be increasing. Significant risk factors were female sex, Hispanic ethnicity, lower BW, younger gestational age, and systemic comorbidities, including perinatal jaundice, patent ductus arteriosus, intraventricular hemorrhage, perinatal sepsis, and respiratory distress syndrome.
Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.
Keywords: National Inpatient Sample; Retinopathy of prematurity.
Copyright © 2022 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study.JAMA Ophthalmol. 2015 Mar;133(3):304-11. doi: 10.1001/jamaophthalmol.2014.5185. JAMA Ophthalmol. 2015. PMID: 25521746 Free PMC article.
-
Retinopathy of Prematurity Among Very Low-Birth-Weight Infants in China: Incidence and Perinatal Risk Factors.Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):757-763. doi: 10.1167/iovs.17-23158. Invest Ophthalmol Vis Sci. 2018. PMID: 29392321
-
Retinopathy of prematurity: a study of prevalence and risk factors.Middle East Afr J Ophthalmol. 2012 Jul-Sep;19(3):289-94. doi: 10.4103/0974-9233.97927. Middle East Afr J Ophthalmol. 2012. PMID: 22837621 Free PMC article.
-
The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP).Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):893-900. doi: 10.1007/s00417-009-1248-6. Epub 2009 Dec 17. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20016911 Free PMC article.
-
Perinatal infection, inflammation, and retinopathy of prematurity.Semin Fetal Neonatal Med. 2012 Feb;17(1):26-9. doi: 10.1016/j.siny.2011.08.007. Epub 2011 Sep 7. Semin Fetal Neonatal Med. 2012. PMID: 21903492 Free PMC article. Review.
Cited by
-
Nationwide Increase in the Incidence of Retinopathy of Prematurity in the US-A Growing Problem?JAMA Ophthalmol. 2023 May 1;141(5):486-487. doi: 10.1001/jamaophthalmol.2023.0926. JAMA Ophthalmol. 2023. PMID: 37052899 Free PMC article. No abstract available.
-
Retinopathy of Prematurity-Targeting Hypoxic and Redox Signaling Pathways.Antioxidants (Basel). 2024 Jan 25;13(2):148. doi: 10.3390/antiox13020148. Antioxidants (Basel). 2024. PMID: 38397746 Free PMC article. Review.
-
Systemic Cytokines in Retinopathy of Prematurity.J Pers Med. 2023 Feb 5;13(2):291. doi: 10.3390/jpm13020291. J Pers Med. 2023. PMID: 36836525 Free PMC article. Review.
-
Global, regional and national burden of retinopathy of prematurity among childhood and adolescent: a spatiotemporal analysis based on the Global Burden of Disease Study 2019.BMJ Paediatr Open. 2024 Jan 6;8(1):e002267. doi: 10.1136/bmjpo-2023-002267. BMJ Paediatr Open. 2024. PMID: 38184302 Free PMC article.
-
Speculum-free retinopathy of prematurity screening with a proparacaine-soaked cotton-swab: A randomized controlled trial in preterm infants.Medicine (Baltimore). 2025 Jul 25;104(30):e43578. doi: 10.1097/MD.0000000000043578. Medicine (Baltimore). 2025. PMID: 40725872 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous